Tongmai Huazhuo Decoction in Treatment of Phlegm and Blood Stasis Mutual Junction Coronary Heart Disease

PANG Li-jian; ZHU Ling-yun; NAN Ming-hua; CHANG Bing-kun; LU Xiao-dong

doi:10.11653/syfj2014010170

您当前的位置：

首页 >

文章列表页 >

Tongmai Huazhuo Decoction in Treatment of Phlegm and Blood Stasis Mutual Junction Coronary Heart Disease

更新时间：2024-01-04

- Tongmai Huazhuo Decoction in Treatment of Phlegm and Blood Stasis Mutual Junction Coronary Heart Disease
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 20, Issue 1, Pages: 170-173(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.11653/syfj2014010170
  CLC：
- Published：2014
- 稿件说明：
移动端阅览
PANG Li-jian, ZHU Ling-yun, NAN Ming-hua, et al. Tongmai Huazhuo Decoction in Treatment of Phlegm and Blood Stasis Mutual Junction Coronary Heart Disease[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(1): 170-173.
DOI：

PANG Li-jian, ZHU Ling-yun, NAN Ming-hua, et al. Tongmai Huazhuo Decoction in Treatment of Phlegm and Blood Stasis Mutual Junction Coronary Heart Disease[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(1): 170-173. DOI： 10.11653/syfj2014010170.

摘要

目的：观察自拟方通脉化浊汤对痰瘀互结型冠心病患者的临床疗效。方法：将120例痰瘀互结型冠心病患者按随机数字表随机分成3组，分别为西药组（常规服用消心痛100 mg口服，3次/d；阿司匹林 100 mg 口服，1次/d）中药1组（西药基础上联合通脉化浊汤），中药2组（西药基础上联合瓜蒌薤白半夏汤合血府逐瘀汤），治疗4周后观察各组疗效。结果：中药1组和中药2组的症状疗效有效率均明显高于西药组（P<0.05），两组的甘油三酯（TC），低密度脂蛋白（LDL-C），载脂蛋白B100（ApoB100），脂蛋白α（LP（α））均明显低于西药组（P<0.05），高密度脂蛋白（HDL-C），ApoA1均明显高于西药组（P<0.05），但两组间比较无差异。结论：通脉化浊汤对痰瘀互结型冠心病疗效显著。

Abstract

Objective: To observe the clinical effect of Tongmai Huazhuo decoction in treating phlegm and blood stasis mutual junction coronary heart disease. Method: One hundred and twenty patients with phlegm and blood stasis mutual junction coronary heart disease were divided into three groups

namely western medicine group (routine treatment which includes Isosorbide dinitrate and Aspirin)

traditional Chinese medicine 1 group(treatment of western medicine and Tongmai Huazhuo decoction)

traditional Chinese medicine 2 group(treatment of western medcine

Gualou Xiebai Guizhi decoction and Xuefu Zhuyu decoction).The curative effect was observed after 4 weeks. Result: The syndrome efficacy rate of both traditional Chinese medicine 1 group and 2 group was apparently higher than that in western medicine group(P<0.05).Indexes of triglycerides(TC)

low-density-lipoprotein-C(LDL-C)

apolipoprotein B100(ApoB100)

lipoprotein α[LP(α)] of the two traditional Chinese groups were significantly lower than those of western medicine group(P<0.05)

and high-density lipoprotein-C(HDL-C)

ApoA1 was higher than that of western medicine group(P<0.05)

but there were no differences between traditional Chinese medicine 1 group and traditional Chinese medicine 2 group. Conclusion: Tongmai Huazhuo decoction has a obvious effect in treatment of phlegm and blood stasis mutual junction coronary heart disease.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Establishment and Evaluation of Rat Model of Myocardial Ischemia-reperfusion Injury with Phlegm and Blood Stasis Blocking Collaterals Syndrome Based on Metabolomics

Establishment and Evaluation of Rat Model of Acute Myocardial Infarction in Coronary Heart Disease with Qi and Yin Deficiency Syndrome Based on Sleep Deprivation Combined with Coronary Artery Ligation

Mechanism of Xuefu Zhuyutang in Intervening in Ferroptosis in Rats with Coronary Heart Disease with Blood Stasis Syndrome Based on ACSL4 Signalling Pathway

Construction of an Intelligent Diagnosis and Treatment Ontology for Traditional Chinese Medicine Based on Clinical Practice Guidelines：A Case Study of Coronary Heart Disease

Effect of Yiqi Huoxue Prescription on cAMP/Epac1/Rap1 Signaling Pathway in Coronary Heart Disease Rats with Qi Deficiency and Blood Stasis Syndrome

Related Author

HU Longxiao

GAO Jiabei

MA Weihao

LU Jieming

GAO Yunxiao

YUAN Yue

ZHANG Qiuyan

CHEN Xiaoxiao

Related Institution

Natural History Museum of China

Beijing Key Laboratory of Chinese Materia Pharmacology，National Clinical Research Center of Traditional Chinese Medicine for Cardiovascular Diseases，Institute of Basic Medical Sciences， Xiyuan Hospital，China Academy of Chinese Medical Sciences

School of Clinical Medicine，Beijing University of Chinese Medicine

Institute of Basic Medical Sciences，Xiyuan Hospital，China Academy of Chinese Medical Sciences

Hunan University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰